AGA Nanotech Secures Major Investment to Form AGA2Tech and Combat Antimicrobial Resistance in Livestock
AGA2tech, a new venture aimed at reducing antimicrobial resistance (AMR) in livestock farming.AGA Nanotech is excited to announce the successful formation of AGA2tech, a new venture aimed at reducing antimicrobial resistance (AMR) in livestock farming. This milestone follows the success of a prestigious Innovate UK Grant awarded to AGA Nanotech, in partnership with GAMA Healthcare, Scotland’s Rural College (SRUC), and the Centre for Innovation Excellence in Livestock (CIEL). The grant supported the development of AGA Nanotech’s proprietary technology to improve pathogen control and reduce the need for antibiotics in animal agriculture.
AGA2Tech was created to exclusively license AGA Nanotech’s technology for animal applications, focusing on livestock such as poultry, pigs, and aquaculture. This innovative approach aims to reduce AMR by enhancing animal health and performance, supporting both food safety and food security. By applying AGA Nanotech’s advanced antimicrobial technologies, AGA2Tech seeks to create sustainable, antibiotic-free solutions for livestock farming, addressing one of the most pressing global challenges in agriculture today.
Quote: “We are thrilled to have secured significant investment to form AGA2tech and further develop our technology for animal applications,” said Adrian Fellows, R&D Director of AGA Nanotech. “Our goal is to reduce the reliance on antibiotics in livestock farming, thereby controlling pathogens more effectively and supporting both food safety and security.”
Livestock farming is a vital component of global food production, but the overuse of antibiotics has contributed to the rise of drug-resistant bacteria, posing serious risks to both animal and human health. AGA2tech will focus efforts on controlling pathogens without the use of antibiotics, thereby safeguarding animal health and enhancing productivity whilst AGA Nanotech will continue to develop the human applications to preserve antiibiotics, protect patients and prevent resistance.
Following Innovate UK Grant Success, AGA Nanotech Forms AGA2Tech to Address Antimicrobial Resistance in Livestock A New Chapter in Sustainable Farming: Reducing AMR and Enhancing Animal Health.